The Hows of Marijuana Legalization

weed Americans have expended tremendous energy debating the why/why not question of marijuana legalization. In contrast, little attention has been given to the hows of marijuana legalization, e.g., would a legal industry be for-profit or non-profit? How and at what level would it be taxed? How would it be regulated? The hows matter enormously. Indeed, once they are spelled out, some people who think they are against marijuana legalization realize that they could support it, and some people who think they are for marijuana legalization realize that they don’t want it after all.

The California Blue Ribbon Commission on Marijuana Policy was set up by the Northern California ACLU to dig into the hows of marijuana legalization. The Commission is not itself going to write a marijuana legalization ballot initiative nor is it going to oppose or endorse any that are written by others. Rather, we are a mix of a think tank and a public education enterprise, encouraging the public to consider carefully what marijuana legalization might look like if it were adopted in California. Everyone is welcome to attend the public events of the Commission as well as to send in their thoughts directly through our website.

My fellow commissioner Professor W. David Ball and I were recently on KQED Forum to discuss the Blue Ribbon Commission’s work. Listening to the broadcast will give you a flavor of the issues with which Californians will have to grapple as they consider the 2016 marijuana legalization ballot initiative(s).

Author: Keith Humphreys

Keith Humphreys is the Esther Ting Memorial Professor of Psychiatry at Stanford University and an Honorary Professor of Psychiatry at Kings College London. His research, teaching and writing have focused on addictive disorders, self-help organizations (e.g., breast cancer support groups, Alcoholics Anonymous), evaluation research methods, and public policy related to health care, mental illness, veterans, drugs, crime and correctional systems. Professor Humphreys' over 300 scholarly articles, monographs and books have been cited over thirteen thousand times by scientific colleagues. He is a regular contributor to Washington Post and has also written for the New York Times, Wall Street Journal, Washington Monthly, San Francisco Chronicle, The Guardian (UK), The Telegraph (UK), Times Higher Education (UK), Crossbow (UK) and other media outlets.